Total Payments
$1,780
2023 Payments
$273.21
Companies
28
Transactions
129
Medicare Patients
6,906
Medicare Billing
$769,044
Payment Breakdown by Category
Food & Beverage$1,780 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,780 | 129 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $390.83 | 39 | $0 (2023) |
| PFIZER INC. | $330.82 | 17 | $0 (2021) |
| Amgen Inc. | $205.62 | 15 | $0 (2023) |
| Lilly USA, LLC | $169.13 | 10 | $0 (2023) |
| ABBVIE INC. | $112.69 | 7 | $0 (2023) |
| Allergan Inc. | $70.27 | 4 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $64.35 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $56.90 | 4 | $0 (2023) |
| Amarin Pharma Inc. | $50.44 | 4 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $41.70 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $273.21 | 16 | Novo Nordisk Inc ($76.29) |
| 2022 | $270.50 | 21 | Novo Nordisk Inc ($121.56) |
| 2021 | $392.78 | 35 | Novo Nordisk Inc ($151.31) |
| 2020 | $269.09 | 14 | PFIZER INC. ($197.70) |
| 2019 | $205.21 | 14 | Amgen Inc. ($87.31) |
| 2018 | $232.51 | 18 | Amgen Inc. ($40.23) |
| 2017 | $136.64 | 11 | PFIZER INC. ($36.29) |
All Payment Transactions
129 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Inflammation | ||||||
| 10/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Oncology | ||||||
| 09/12/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 09/05/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Obesity | ||||||
| 07/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Gastroenterology | ||||||
| 07/25/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Biological | ||||||
| 05/18/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: INSOMNIA | ||||||
| 05/08/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Diabetes | ||||||
| 04/26/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Urology | ||||||
| 03/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Cardiology | ||||||
| 03/07/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 02/28/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 02/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 02/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 01/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), SHINGRIX | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: VACCINES | ||||||
| 10/25/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Diabetes | ||||||
| 10/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Neuroscience | ||||||
| 09/28/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Urology | ||||||
| 08/31/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Obesity | ||||||
| 08/11/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.35 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,665 | 2,852 | $429,319 | $197,332 |
| 2022 | 22 | 1,658 | 2,808 | $422,624 | $190,206 |
| 2021 | 19 | 1,744 | 2,984 | $434,575 | $198,598 |
| 2020 | 22 | 1,839 | 3,229 | $402,693 | $182,907 |
Total Patients
6,906
Total Services
11,873
Medicare Billing
$769,044
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 416 | 1,091 | $208,381 | $82,239 | 39.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 355 | 355 | $76,325 | $42,391 | 55.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 199 | 318 | $42,612 | $17,558 | 41.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 47 | 47 | $16,920 | $12,691 | 75.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 166 | 168 | $22,008 | $12,557 | 57.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 44 | 59 | $24,308 | $11,811 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 169 | 171 | $8,037 | $4,891 | 60.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 31 | 31 | $8,556 | $4,752 | 55.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $4,624 | $2,457 | 53.1% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 18 | 303 | $5,757 | $2,226 | 38.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 45 | 45 | $2,115 | $1,287 | 60.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 93 | $3,906 | $853.95 | 21.9% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 20 | 20 | $1,700 | $530.80 | 31.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 16 | 17 | $1,462 | $524.85 | 35.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 29 | 32 | $832.00 | $250.32 | 30.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 14 | $490.00 | $126.48 | 25.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 13 | 13 | $416.00 | $123.76 | 29.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 19 | 58 | $870.00 | $62.73 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 414 | 1,043 | $199,213 | $78,532 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 342 | 342 | $73,530 | $41,623 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 262 | 377 | $50,518 | $19,251 | 38.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 53 | 64 | $26,368 | $12,917 | 49.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 136 | 138 | $18,072 | $9,660 | 53.5% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 21 | 21 | $8,329 | $5,234 | 62.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 33 | 33 | $8,976 | $5,166 | 57.6% |
About Dr. Mae Fischer, M.D
Dr. Mae Fischer, M.D is a Internal Medicine healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518036177.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mae Fischer, M.D has received a total of $1,780 in payments from pharmaceutical and medical device companies, with $273.21 received in 2023. These payments were reported across 129 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($1,780).
As a Medicare-enrolled provider, Fischer has provided services to 6,906 Medicare beneficiaries, totaling 11,873 services with total Medicare billing of $769,044. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Paducah, KY
- Active Since 11/07/2006
- Last Updated 05/30/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1518036177
Products in Payments
- Ozempic (Drug) $163.64
- COLOGUARD (Device) $122.23
- Aimovig (Biological) $88.74
- Rybelsus (Drug) $72.99
- UBRELVY (Drug) $65.78
- XIFAXAN (Drug) $64.35
- FLECTOR (Drug) $59.47
- COLOGUARD DNA CAPTURE REAGENTS (Device) $50.86
- Vascepa (Drug) $50.44
- CHANTIX (Drug) $48.82
- BYSTOLIC (Drug) $47.41
- VRAYLAR (Drug) $46.91
- MOUNJARO (Drug) $46.53
- TRULICITY (Drug) $41.95
- Prolia (Biological) $39.30
- LYRICA (Drug) $38.76
- EVENITY (Biological) $36.33
- BASAGLAR (Drug) $35.72
- JARDIANCE (Drug) $31.58
- Myrbetriq (Drug) $31.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Paducah
Dr. Martin Rains, M.d, M.D
Internal Medicine — Payments: $48,397
Internal Medicine $48,397
Dr. Wederson Claudino, Md, MD
Internal Medicine — Payments: $29,178
Internal Medicine $29,178
Jacob Elrod, Md, MD
Internal Medicine — Payments: $24,847
Internal Medicine $24,847
Michael Faulkner, M.d, M.D
Internal Medicine — Payments: $16,943
Internal Medicine $16,943
Ryan Frazine, M.d, M.D
Internal Medicine — Payments: $10,062
Internal Medicine $10,062
Dr. Van Meeks, M.d, M.D
Internal Medicine — Payments: $7,786
Internal Medicine $7,786